142 related articles for article (PubMed ID: 9043277)
1. Wound fluids and the pathogenesis of chronic wounds.
Wysocki AB
J Wound Ostomy Continence Nurs; 1996 Nov; 23(6):283-90. PubMed ID: 9043277
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes.
Rao CN; Ladin DA; Liu YY; Chilukuri K; Hou ZZ; Woodley DT
J Invest Dermatol; 1995 Oct; 105(4):572-8. PubMed ID: 7561161
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin profiles in normal and chronic wound fluid.
Wysocki AB; Grinnell F
Lab Invest; 1990 Dec; 63(6):825-31. PubMed ID: 2255189
[TBL] [Abstract][Full Text] [Related]
5. [Matrix metalloproteinases MMP-2 and MMP-9 of wound and burn exudates and their effect on extracellular matrix proteins].
Voronkina IV; Kokorin KV; Chulikov OV; Paramonov BA; Blinova MI; Pinaev GP
Tsitologiia; 2003; 45(1):43-50. PubMed ID: 12683235
[TBL] [Abstract][Full Text] [Related]
6. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid.
Baker EA; Leaper DJ
Wound Repair Regen; 2000; 8(5):392-8. PubMed ID: 11115151
[TBL] [Abstract][Full Text] [Related]
7. Prolidase activity in chronic wound and blister fluids.
Oono T; Fujiwara Y; Yoshioka T; Arata J
J Dermatol; 1997 Oct; 24(10):626-9. PubMed ID: 9375460
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin.
Grinnell F; Zhu M
J Invest Dermatol; 1996 Feb; 106(2):335-41. PubMed ID: 8601737
[TBL] [Abstract][Full Text] [Related]
9. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
11. Uncontrolled gelatin degradation in non-healing chronic wounds.
Trøstrup H; Holstein P; Karlsmark T; Moser C; Ågren MS
J Wound Care; 2018 Nov; 27(11):724-734. PubMed ID: 30398935
[TBL] [Abstract][Full Text] [Related]
12. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9.
Tarlton JF; Vickery CJ; Leaper DJ; Bailey AJ
Br J Dermatol; 1997 Oct; 137(4):506-16. PubMed ID: 9390324
[TBL] [Abstract][Full Text] [Related]
13. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
Siméon A; Monier F; Emonard H; Gillery P; Birembaut P; Hornebeck W; Maquart FX
J Invest Dermatol; 1999 Jun; 112(6):957-64. PubMed ID: 10383745
[TBL] [Abstract][Full Text] [Related]
14. [IV--Chronic wounds].
Téot L
Soins; 2004 May; (685):21-3. PubMed ID: 15208951
[No Abstract] [Full Text] [Related]
15. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays.
Grinnell F; Ho CH; Wysocki A
J Invest Dermatol; 1992 Apr; 98(4):410-6. PubMed ID: 1372338
[TBL] [Abstract][Full Text] [Related]
16. Chronic wound fluid--thinking outside the box.
Widgerow AD
Wound Repair Regen; 2011; 19(3):287-91. PubMed ID: 21518088
[TBL] [Abstract][Full Text] [Related]
17. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer.
Rayment EA; Upton Z; Shooter GK
Br J Dermatol; 2008 May; 158(5):951-61. PubMed ID: 18284390
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin in acute and chronic wounds.
Wysocki AB
J ET Nurs; 1992; 19(5):166-70. PubMed ID: 1420529
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds.
Bullen EC; Longaker MT; Updike DL; Benton R; Ladin D; Hou Z; Howard EW
J Invest Dermatol; 1995 Feb; 104(2):236-40. PubMed ID: 7829879
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
